stars 1 stars 2 stars 3

PIPRA has developed a cutting-edge AI-based pre-surgical tool to assess patients’ risk of suffering from POD or POCD. A reliable pre-surgical risk assessment is urgently needed to improve preventive measures, consequent surgical outcomes and thus patients’ quality of life. POCD & POD More than 25% of patients aged over 60 suffer from cognitive impairment due to surgical complications. Disorientation, memory loss, difficulty in speech, and behavioral changes are among the symptoms experienced by patients affected by Post-Operative Delirium (POD) and Post-Operative Cognitive Decline/Dysfunction (POCD). These cognitive disorders result in a longer post-surgical recovery time, with increased hospital stays and associated costs. In addition, the most severe forms of perioperative cognitive disorders can lead to the admission in nursing homes due to significant functional and cognitive decline. Today, there is no effective POD and POCD treatment currently available. It is therefore crucial to prevent the onset of these disorders.

View Top Employees from PIPRA AG
Website http://pipra.ch
Employees 14 (8 on RocketReach)
Founded 2019
Technologies
Industry Medical Equipment Manufacturing

PIPRA AG Questions

Nayeli Schmutz is the Co-founder and Chief Medical Officer. of PIPRA AG.

8 people are employed at PIPRA AG.

Top PIPRA AG Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users